Brian Wells to Proportional Hazards Models
This is a "connection" page, showing publications Brian Wells has written about Proportional Hazards Models.
Connection Strength
0.491
-
Lenchik L, Lenoir KM, Tan J, Boutin RD, Callahan KE, Kritchevsky SB, Wells BJ. Opportunistic Measurement of Skeletal Muscle Size and Muscle Attenuation on Computed Tomography Predicts 1-Year Mortality in Medicare Patients. J Gerontol A Biol Sci Med Sci. 2019 06 18; 74(7):1063-1069.
Score: 0.150
-
Choi I, Kattan MW, Wells BJ, Yu C. A hybrid approach to survival model building using integration of clinical and molecular information in censored data. IEEE/ACM Trans Comput Biol Bioinform. 2012 Jul-Aug; 9(4):1091-1105.
Score: 0.093
-
Wells BJ, Jain A, Arrigain S, Yu C, Rosenkrans WA, Kattan MW. Predicting 6-year mortality risk in patients with type 2 diabetes. Diabetes Care. 2008 Dec; 31(12):2301-6.
Score: 0.071
-
Wells BJ, Mainous AG, King DE, Gill JM, Carek PJ, Geesey ME. The combined effect of transferrin saturation and low density lipoprotein on mortality. Fam Med. 2004 May; 36(5):324-9.
Score: 0.053
-
Kannan S, Pantalone KM, Matsuda S, Wells BJ, Karafa M, Zimmerman RS. Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic. J Diabetes. 2016 Mar; 8(2):279-85.
Score: 0.029
-
Sun GE, Wells BJ, Yip K, Zimmerman R, Raghavan D, Kattan MW, Kashyap SR. Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus. Diabetes Obes Metab. 2014 Mar; 16(3):276-83.
Score: 0.026
-
Choi I, Wells BJ, Yu C, Kattan MW. An empirical approach to model selection through validation for censored survival data. J Biomed Inform. 2011 Aug; 44(4):595-606.
Score: 0.021
-
Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis. Acta Diabetol. 2009 Jun; 46(2):145-54.
Score: 0.018
-
Everett CJ, Wells BJ, Frithsen IL, Koopman RJ. Smoking, fibrinogen and cancer mortality. J Natl Med Assoc. 2007 Apr; 99(4):328-33.
Score: 0.016
-
Mainous AG, Eschenbach SL, Wells BJ, Everett CJ, Gill JM. Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort. Fam Med. 2005 Jan; 37(1):36-42.
Score: 0.014